Ylenia Della Rocca | Medicine and Health Sciences | Research Excellence Award

Published on by Research Awards

Prof. Ylenia Della Rocca | Medicine and Health Sciences | Research Excellence Award 

Link University | Italy

Ylenia Della Rocca is an Associate Professor of Histology and Embryology and Physiology whose research profile is internationally recognized in the fields of stem cell biology, regenerative medicine, and advanced in vitro modeling for precision medicine. Her scientific activity is strongly interdisciplinary, integrating histology, embryology, molecular biology, biomaterials, and translational medicine, with a particular focus on induced pluripotent stem cells (iPSCs), extracellular vesicles, and 3D culture systems. Her core research line centers on the reprogramming of autologous human gingival mesenchymal stem cells into iPSCs and their differentiation toward functional cell types, especially cardiomyocytes and neural lineages. This work has led to innovative strategies for cardiac regeneration and personalized regenerative therapies, culminating in a patented non-integrative reprogramming and cardiomyogenic differentiation process. Through advanced molecular and morphological analyses, her studies elucidate the signaling pathways governing cell fate, inflammation, hypoxia response, and extracellular matrix remodeling. A distinctive element of her research is the development and application of organ-on-a-chip and tissue-on-a-chip platforms, including bone-on-a-chip and cardiac models, to study disease mechanisms, environmental pollutant toxicity, and therapeutic responses. Within national and international projects, she has contributed to the creation of physiologically relevant in vitro systems that reduce reliance on animal models while increasing translational relevance. Her work on environmental pollutants, such as bisphenol A and pesticides, has clarified their impact on inflammatory, apoptotic, and epigenetic pathways in stem cells and endothelial models.

View Orcid Profile

Featured Publications

Zbigniew Rybak | Health Professions | Research Excellence Award

Published on by Research Awards

Prof. Zbigniew Rybak | Health Professions | Research Excellence Award

Wroclaw Medical University | Poland

Prof. Zbigniew Rybak, MD, Ph.D. is a distinguished surgeon, academic, and innovator whose career spans five decades of clinical excellence, research leadership, and medical education. He has been continuously affiliated with Wrocław Medical University from 1975 to 2025, where he has played a pivotal role in advancing experimental surgery, vascular surgery, and biomaterials research. From 2010 to 2022, he served as Head of the Department of Experimental Surgery and Biomaterials Research, leading interdisciplinary research that bridged surgical practice with biomedical engineering and translational medicine. His later appointment at the Pre-Clinical Research Centre (2022–2025) further strengthened preclinical innovation and surgical modeling. Prof. Rybak’s international experience includes clinical and research work at Rikshospitalet, The National Hospital of Norway (1979–1981), and collaboration with the Department for Cardiovascular, General and Transplantation Surgery at Oslo Medical University, significantly enriching his global surgical perspective. Prof. Rybak is a prolific medical innovator and holds five patents addressing critical needs in surgery and biomedical technology, including devices for anorectal disease diagnosis and treatment, biomedical glue, pharmaceutical carriers, nanochloroapatite preparation processes, and a medical bed design. These inventions reflect his commitment to translating research into practical, patient-centered solutions. His research interests focus on vascular surgery, chronic wound management, biomaterials, minimally invasive and endovascular therapies, and the development of hybrid surgical techniques. A recognized leader in medical education, Prof. Rybak has led international surgical training courses across Europe, Asia, and the Americas. He has trained approximately 250 physicians in laser treatment of venous insufficiency, over 1,000 physicians in sclerotherapy since 2006, and 80 physicians in steam-based venous treatment techniques.

Citation Metrics (Scopus)

3000
2000
1000
  500
  400
  300
  200
  100
    50
    30
    10
      0

Citations
2502

Documents
92

h-index
19

Citations

h-index

i10-index

View Scopus Profile

Featured Publications

Ferdinando D’Amico | Medicine and Health Sciences | Best Researcher Award

Published on by Research Awards

Ferdinando D’Amico | Medicine and Health Sciences | Best Researcher Award

Dr Ferdinando D’Amico, IRCCS San Raffaele Hospital, Italy

Dr. Ferdinando D’Amico is a distinguished gastroenterologist at IRCCS San Raffaele Hospital in Milan, Italy, with expertise in gastroenterology and endoscopy. 🎓 He completed his residency in Gastroenterology/Digestive Diseases and earned his PhD at Hunimed University, focusing on histology in inflammatory bowel diseases. His academic journey includes a degree in Medicine and Surgery from “Cattolica del Sacro Cuore” University, where he researched intestinal permeability and atherosclerosis. 🏥 His training included internships in gastroenterology and cardiology at “Agostino Gemelli” Hospital in Rome. Dr. D’Amico is proficient in English and French, and skilled in digital communication. 🌍🔬

Publication profile

Scopus

Education 

🎓 From 2003 to 2008, attended Classical High School, graduating with highest honours. From 2009 to 2015, pursued a Degree in Medicine and Surgery at “Cattolica del Sacro Cuore” University, Rome, also graduating with highest honours. 🏆 The dissertation, titled “Alterations in Intestinal Permeability and Inflammation: A Novel Potential Mechanism of Atherosclerosis,” was supervised by Professor Filippo Crea. 📜 Currently registered with the Ordine Provinciale dei Medici Chirurghi e degli Odontoiatri di Caserta, registration number 7593. 🩺

Experience

From November 1, 2016, to November 2, 2020, [Name] completed their residency in Gastroenterology/Digestive System Diseases at Hunimed University in Pieve Emanuele, Italy, graduating with highest honors. They then pursued a Ph.D. at the same institution, focusing on “The Role of Histology in Inflammatory Bowel Diseases,” under the guidance of Prof. Silvio Danese. From January 1, 2021, to February 9, 2024, they worked as a Gastroenterologist at the IRCCS San Raffaele Hospital in Milan, Italy, in the Gastroenterology and Endoscopy Unit, also directed by Prof. Silvio Danese. 🏥📚🩺

Research focus

Based on the provided publications, the research focus appears to be on inflammatory bowel diseases (IBD), specifically Crohn’s disease and ulcerative colitis. The studies address various aspects such as comparing treatments (e.g., tofacitinib vs. ustekinumab), assessing remission through non-invasive methods, and evaluating regulatory guidance for JAK inhibitors. The research also explores the use of biologics and other therapies in managing IBD, including switching between different treatment forms. This indicates a strong emphasis on optimizing treatment strategies and improving patient outcomes in IBD. 🌟📚💊

Publication top notes

Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study

Ultrasound remission after biologic induction and long-term endoscopic remission in Crohn’s disease: a prospective cohort study

Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study

The role of filgotinib in ulcerative colitis and Crohn’s disease

A new national survey of centers for cognitive disorders and dementias in Italy

An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study

Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn’s disease

MMX mesalamine in ulcerative colitis: Major advantages towards classical mesalamine formulations

Advancing transmural remission as a treatment target in Crohn’s disease: The future of tight-control strategy?

Noninvasive Assessment of Postoperative Disease Recurrence in Crohn’s Disease: A Multicenter, Prospective Cohort Study on Behalf of the Italian Group for Inflammatory Bowel Disease

 

 

Valery Likhvantsev | Medicine and Health Sciences | Russia

Published on by Research Awards

Prof Dr. Valery Likhvantsev | Medicine and Health Sciences | Russia

Deputy Director at Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Russia.

Amjad Alipanah is an esteemed Associate Professor of Applied Mathematics at the University of Kurdistan, Sanandaj, Iran. Born on September 23, 1974, he has a distinguished academic background with a BSc in Mathematics from the University of Kurdistan and both an MSc and PhD in Applied Mathematics from AmirKabir University, Tehran, Iran. His research focuses on spectral and pseudospectral methods, finite difference methods, calculus of variations, approximation theory, and numerical analysis. With a robust portfolio of journal publications and conference papers, he has significantly contributed to the field. Alipanah is also a dedicated educator, teaching a variety of undergraduate and graduate courses and supervising numerous postgraduate theses. His work has earned him top ranks as a graduate student and a prominent position in the academic community. 🌐✨

Professional Profiles:

Education

Valery Likhvantsev’s education details are not explicitly provided in the information available. To accurately provide his educational background, additional specific details about his academic journey, such as the institutions he attended, degrees he obtained, and fields of study, would be required. However, considering his high level of research activity and professional accomplishments, it can be inferred that he has a robust educational foundation in medicine or a related field, likely including advanced degrees such as an MD or PhD.

Professional Experience

Valery Likhvantsev is currently affiliated with the Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology since 2020. His extensive professional experience spans various roles and contributions to the field of anesthesiology and intensive care. Likhvantsev has authored and co-authored numerous publications in high-impact journals, reflecting his active engagement in clinical research and his commitment to advancing medical knowledge in his specialty. His work includes significant contributions to contemporary clinical trials, systematic reviews, and meta-analyses, focusing on topics such as neurocognitive disorders, sepsis, and postoperative outcomes. His professional journey underscores a deep commitment to clinical excellence and research innovation in critical care medicine.

Research Interest

Valery Likhvantsev’s research interests primarily revolve around anesthesiology and intensive care medicine. His work extensively covers the effects of anesthetics on postoperative neurocognitive disorders, the use of anti-inflammatory agents in sepsis, and strategies to reduce postoperative agitation through innovative anesthetic techniques. Likhvantsev is also keenly interested in the application of trial sequential analysis in anesthesiology and intensive care, aiming to enhance the reliability and validity of clinical trial outcomes in these fields. His research is characterized by a rigorous approach to understanding and improving patient outcomes through evidence-based practices and innovative therapeutic interventions.

Award and Honors

Valery Likhvantsev has been recognized for his significant contributions to anesthesiology and intensive care medicine. His awards and honors reflect his dedication to advancing the field through innovative research and clinical excellence. He has received multiple accolades for his published works, highlighting the impact and importance of his research in improving patient outcomes and advancing medical knowledge. These honors underline Likhvantsev’s role as a leading figure in his area of expertise, acknowledging his commitment to excellence and his influence in shaping contemporary anesthesiology and intensive care practices.

Research Skills

Valery Likhvantsev possesses a robust set of research skills that underscore his expertise in anesthesiology and intensive care medicine. His proficiency in clinical trial design and implementation ensures rigorous and reliable study outcomes, while his adeptness in systematic reviews and meta-analyses enables comprehensive evaluations of existing research. He is skilled in statistical analysis, which allows for precise interpretation of complex data, and his ability to conduct trial sequential analysis adds a layer of depth to his research. Additionally, Likhvantsev is proficient in writing and publishing scholarly articles, contributing to high-impact journals in his field, thus disseminating crucial findings to the wider medical community.

Publications

  1. Sevoflurane Multiple Wash In/Wash Out at the End of Anesthesia to Reduce Agitation: A Multicenter Double-Blind Randomized Controlled Trial
    • Authors: Landoni, G., Likhvantsev, V.V., Berikashvili, L.B., Pivovarova, A.A., Shemetova, M.M.
    • Year: 2024
    • Citations: 0
    • Journal: Contemporary Clinical Trials Communications
  2. Trial Sequential Analysis in Anesthesiology and Intensive Care: A Systematic Review | Последовательный анализ исследований в анестезиологии и реаниматологии: систематический обзор
    • Authors: Yadgarov, M.Ya., Berikashvili, L.B., Polyakov, P.A., Yakovlev, A.A., Likhvantsev, V.V.
    • Year: 2024
    • Citations: 0
    • Journal: Patologiya Krovoobrashcheniya i Kardiokhirurgiya
  3. Intraoperative Electroencephalogram Patterns as Predictors of Postoperative Delirium in Older Patients: A Systematic Review and Meta-Analysis
    • Authors: Likhvantsev, V.V., Berikashvili, L.B., Smirnova, A.V., Shemetova, M.M., Kuzovlev, A.N.
    • Year: 2024
    • Citations: 0
    • Journal: Frontiers in Aging Neuroscience
  4. Effect of Regional Anesthesia on Oncological Outcomes (Meta-Analysis)
    • Authors: Kadantseva, K.K., Yadgarov, M.Ya., Subbotin, V.V., Kuzovlev, A.N., Likhvantsev, V.V.
    • Year: 2024
    • Citations: 0
    • Journal: Obshchaya Reanimatologiya
  5. Melatonin as Adjuvant Treatment in COVID-19 Patients: A Meta-Analysis of Randomized and Propensity Matched Studies
    • Authors: Tóth, K., Pilia, E., Landoni, G., Székely, A., Covello, R.D.
    • Year: 2024
    • Citations: 0
    • Journal: Signa Vitae
  6. Hypotension-Avoidance Versus Hypertension-Avoidance Strategies in Noncardiac Surgery
    • Authors: Marcucci, M., Painter, T.W., Conen, D., Yusuf, S., Devereaux, P.J.
    • Year: 2023
    • Citations: 1
    • Journal: Annals of Internal Medicine
  7. Effects of Early Postoperative Neurocognitive Disorders on Clinically Relevant Outcomes: A Meta-Analysis
    • Authors: Likhvantsev, V.V., Landoni, G., Berikashvili, L.B., Makarevich, D.M., Grechko, A.V.
    • Year: 2023
    • Citations: 2
    • Journal: Korean Journal of Anesthesiology
  8. High Dose Esomeprazole as an Anti-Inflammatory Agent in Sepsis: Protocol for a Randomized Controlled Trial
    • Authors: Monti, G., Konkayev, A., Carta, S., Usai, B., De Sio, A.
    • Year: 2023
    • Citations: 0
    • Journal: Contemporary Clinical Trials
  9. Anakinra for Patients with COVID-19: An Updated Systematic Review and Meta-Analysis
    • Authors: Cavalli, G., Navalesi, P., Landoni, G., Monti, G., Pasin, L.
    • Year: 2023
    • Citations: 1
    • Journal: Signa Vitae
  10. Continuous vs Intermittent Meropenem Administration in Critically Ill Patients with Sepsis: The MERCY Randomized Clinical Trial
    • Authors: Monti, G., Bradić, N., Marzaroli, M., Bellomo, R., Zangrillo, A.
    • Year: 2023
    • Citations: 22
    • Journal: JAMA